• Explore /
  • Poster
  • / LAG3-related factors to predict response to nivolumab monotherapy in advanced gastric cancer (WJOG10417GTR study).

LAG3-related factors to predict response to nivolumab monotherapy in advanced gastric cancer (WJOG10417GTR study).

Abstract Poster

Authors

null

Kai Tsugaru

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan;

Kai Tsugaru , Narikazu Boku , Chie Kudo-Saito , Hirokazu Shoji , Hiroshi Imazeki , Naoki Takahashi , Takeshi Kawakami , Yusuke Amanuma , Takeru Wakatsuki , Naohiro Okano , Yukiya Narita , Yoshiyuki Yamamoto , Rika Kizawa , Kengo Nagashima , Kazunori Aoki , Kei Muro

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Translational Research

Clinical Trial Registration Number

UMIN000032686

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 425)

DOI

10.1200/JCO.2023.41.4_suppl.425

Abstract #

425

Poster Bd #

J9

Abstract Disclosures

Similar Posters

First Author: David Silva Moura

First Author: Katherine M. Bever

First Author: Daisuke Takahari

Poster

2019 Gastrointestinal Cancers Symposium

Activation of central/effector memory T cells in advanced gastric cancer patients treated with antiprogrammed death-1 antibody.

Activation of central/effector memory T cells in advanced gastric cancer patients treated with antiprogrammed death-1 antibody.

First Author: Hirofumi Ohmura